Almost 50 million (22.2%) adult Americans over 18 were diagnosed with arthritis in 2007–2009, most significantly osteoarthritis and the autoimmune disease rheumatoid arthritis. (Centers for Disease Control and Prevention (CDC) A projects an increase to 67 million is by 2030
Some arthritis treatments may have side-effect caused by active compounds as well as the way there are administrated. Cannabidiol (CBD) weaken inflammation and pain without side-effects.
Components of Cannabis demonstrate anti-inflammatory action, by suppressing the synthesis of eicosanoids that promote the initiation of the inflammatory process
Cannabinoids and cannabinoid receptors have been studied as potential goal for reducing pain and inflammation associated with osteoarthritis and rheumatoid arthritis
One study conducted looked at the effectiveness of transdermal CBD applications to reduce inflammation and pain from adjuvant-induced monoarthritic knee joint model, measuring adverse effects.
The data collected revealed that the topical CBD application has therapeutic capability for relief of arthritis pain-related activities and inflammation without evident side-effects.
Results from Data
Cannabinoid side-effects varied and it depended on several factors like administrated dose and the route of administration.
Transdermal CBD gel doses were admitted between 6.2 and 62 mg/day, demostrated a significant reduction in joint swelling, spontaneous pain, immune cell infiltration and thickening of the synovial membrane in a dose-dependent manner.
Using a topical CBD application, avoids gastrointestinal usage and provides more a constant plasma levels doses of CBD.
Transdermal cannabidiol (CBD) gel application has therapeutic potential for relief of arthritic pain-related behaviors and utilizes an anti-inflammation property without evident high brain center psychoactive effects, others words, it will not get you high. Check out our CBD Hemp Extract Patches the are available for purchase.